...
首页> 外文期刊>Journal of Young Pharmacists >Simultaneous Analytical Method Development of 6-Mercaptopurine and 6-Methylmercaptopurine in Plasma by High Performance Liquid Chromatography-Photodiode Array
【24h】

Simultaneous Analytical Method Development of 6-Mercaptopurine and 6-Methylmercaptopurine in Plasma by High Performance Liquid Chromatography-Photodiode Array

机译:高效液相色谱-光电二极管阵列同时开发血浆中6-巯基嘌呤和6-甲基巯基嘌呤的分析方法

获取原文
           

摘要

Objective: 6-Mercaptopurin is antineoplastic drug that is included in antimetabolite group and is used in acute lymphoblastic leukemia medication. 6-Mercaptopurin is inactive pro-drug that will be metabolized into metabolites. One of its metabolites is 6-methylmercaptopurine. This study is aimed to optimize the analytical conditions and perform validation for the analysis of 6-mercaptopurine and 6-methylmercaptopurine in plasma. Method: Separation was performed using Waters 2996 HPLC, C18 SunfireTM column (5μm, 250 x 4.6 mm) with the mobile phase containing water-methanol-acetonitrile with gradient elution, and detected at 303 nm. 5-Fluorouracil was used as internal standard. Plasma extraction was done by liquid-liquid extraction using dichloromethane. Result: The method was linear at concentration range of 2.0 – 200.0 ng/mL with r > 0.9991 for 6-mercaptopurine and 20 – 2000 ng/mL with r > 0.9993 for 6-methylmercaptopurine. Accuracy and precision within-run and between-run fulfill the acceptance criteria with % RE and relative standard deviation (% RSD) ≤ 20% (LLOQ) and ≤ 15% (QC samples). 6-Mercaptopurine and 6-methylmercaptopurine was stable in plasma at least for 21 days when stored at -20oC. Conclusion: The bio-analytical method was sensitive, selective and all the parameters fulfilled the acceptance criteria of the EMA Bio-analytical Method Validation Guideline, 2011.
机译:目的:6-巯基嘌呤是抗肿瘤药,属于抗代谢药物组,用于急性淋巴细胞白血病药物。 6-巯基嘌呤是无活性的前药,将被代谢成代谢产物。它的代谢产物之一是6-甲基巯基嘌呤。这项研究旨在优化分析条件,并进行血浆中6-巯基嘌呤和6-甲基巯基嘌呤分析的验证。方法:使用Waters 2996 HPLC,C18 SunfireTM色谱柱(5μm,250 x 4.6 mm)进行分离,流动相中含有水-甲醇-乙腈并进行梯度洗脱,并在303 nm处检测到。使用5-氟尿嘧啶作为内标。通过使用二氯甲烷的液-液萃取进行血浆萃取。结果:该方法在6-巯基嘌呤的浓度范围为2.0 – 200.0 ng / mL,r> 0.9991时为线性;对于6-甲基巯基嘌呤的浓度范围为20 – 2000 ng / mL,r> 0.9993。批内和批间的准确度和精密度满足可接受标准,%RE和相对标准偏差(%RSD)≤20%(LLOQ)和≤15%(QC样品)。当在-20oC下保存时,6-巯基嘌呤和6-甲基巯基嘌呤在血浆中至少稳定21天。结论:该生物分析方法灵敏,选择性好,所有参数均符合《 2011年EMA生物分析方法验证指南》的接受标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号